M
Marjorie De la Fuente
Researcher at University of Chile
Publications - 32
Citations - 3913
Marjorie De la Fuente is an academic researcher from University of Chile. The author has contributed to research in topics: Intestinal mucosa & Cancer. The author has an hindex of 13, co-authored 29 publications receiving 2231 citations. Previous affiliations of Marjorie De la Fuente include Pontifical Catholic University of Chile.
Papers
More filters
Journal ArticleDOI
Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases.
Daniela Parada Venegas,Marjorie De la Fuente,Glauben Landskron,María-Julieta González,Rodrigo Quera,Gerard Dijkstra,Hermie J. M. Harmsen,Klaas Nico Faber,Marcela A. Hermoso +8 more
TL;DR: An overview of microbial SCFAs production and their effects on the intestinal mucosa with specific emphasis on their relevance for Inflammatory Bowel Diseases is presented and the therapeutic potential ofSCFAs for IBD is discussed.
Journal ArticleDOI
Chronic inflammation and cytokines in the tumor microenvironment.
TL;DR: The role of these cytokines in important events of carcinogenesis, such as their capacity to generate reactive oxygen and nitrogen species, their potential mutagenic effect, and their involvement in mechanisms for epithelial mesenchymal transition, angiogenesis, and metastasis are explored.
Journal ArticleDOI
Corrigendum: Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases (Frontiers in Immunology (2019) 10 (277) DOI: 10.3389/fimmu.2019.00277)
Daniela Parada Venegas,Marjorie De la Fuente,Glauben Landskron,María-Julieta González,Rodrigo Quera,Gerard Dijkstra,Hermie J. M. Harmsen,Klaas Nico Faber,Marcela A. Hermoso +8 more
Journal ArticleDOI
The IL-33/ST2 axis: Role in health and disease.
TL;DR: The role of the IL-33/ST2 axis is involved in the pathogenesis of atopic and autoimmune diseases, cancer, and central nervous system disorders, and recent findings on the role are reviewed.
Journal ArticleDOI
Glucocorticosteroid therapy in inflammatory bowel diseases: From clinical practice to molecular biology
Karen Dubois-Camacho,Payton A. Ottum,Daniel Franco-Muñoz,Marjorie De la Fuente,Alejandro Torres-Riquelme,David Díaz-Jiménez,Mauricio Olivares-Morales,Gonzalo Astudillo,Rodrigo Quera,Marcela A. Hermoso +9 more
TL;DR: A thorough analysis of current clinical and biomedical literature may help guide physicians in determining a course of treatment for IBDs patients and identifies important areas needing further study.